Revenue ($USD) : $9,400,000,000
R&D spend : $828,000,000
Employees : 25,000
Fiscal year end : 12/31/2023
CEO : David Endicott

www.alcon.com

Formerly a subsidiary of pharmaceutical giant Novartis, Alcon spun out as a separate eye care business in 2019. The company was founded in 1945 by Robert Alexander and William Conner as a small pharmacy in Fort Worth, Texas, where its U.S. headquarters remain. In 2024, Alcon expanded its glaucoma portfolio with the acquisition of Belkin Vision and broadened its cataract offerings with FDA clearance for two of its Unity offerings. The company anticipates around $10 billion in sales for fiscal 2024. –SW